sotorasib,docetaxel
amgen,sanofi,aventis
['sotorasib', 'codebreak 200', 'docetaxel']
 presidential symposium codebreak 200 study: met its primary endpoint with sotorasib demonstrating superior pfs over
docetaxel (hr 0.66, p = 0.002); 12-month pfs rate was 24.8% for sotorasib and 10.1% for docetaxel #esmo22 
Pursuing to improve cancer prevention and care. Medical Oncologist @AnkaraUni